Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • Ratan Tata invests in...

    Ratan Tata invests in MUrgency

    Written by savita thakur thakur Published On 2016-05-18T12:38:36+05:30  |  Updated On 14 Aug 2021 11:44 AM IST

    New Delhi : Tata Sons Chairman Emeritus Ratan Tata has invested in San Francisco-based medical emergency response startup MUrgency Inc.


    Financial details of the deal were not disclosed.


    "He (Tata) clearly wanted us to launch and grow the network in India first before taking it overseas. Mr Tata's investment in MUrgency will help attract leading talent to the company and major partnerships beyond India," MUrgency Inc Fonder Shaffi Mather said in a statement.


    Founded in 2014 in Silicon Valley and incubated out of Stanford ChangeLabs, MUrgency recently received investments from Kris Gopalakrishnan and S D Shibulal led Axilor Ventures.


    The company launched its service in Tricity area in Punjab on February 16, with a responder network of 36 hospital emergency rooms, over 40 ambulances and more than 350 medical professionals.


    MUrgency is slated to launch services in Amritsar and Jalandhar in the last week of May and cover the entire state by June end. The company plans to go pan-India by 2018 and around the world by 2020.


    The company claims to make emergency response available with just one tap on a mobile phone in under nine minutes in urban areas.


    MUrgency will use the proceeds of the funding to augment technology and scale operations besides leveraging Tata's experience and network as a global business leader to develop the emergency response network globally through appropriate partnerships.


    Ratan Tata has made more than 25 investments in startups in the last two years. Healthcare firms that have benefitted include Lybrate, Swasth India and Invictus Oncology.


    Apart from MUrgency, Tata's overseas investments include Boston-based wind energy startup Altaeros Energies, China's largest smartphone maker Xiaomi and Singapore-based Crayon Data, a big data analytics firm.


    "While our primary goal is to develop emergency medical response network, we are widening our service to be an inclusive and comprehensive medical service platform on your mobile phone. The app is live on iOS and Android app stores and several features are accessible across the world already," Sweta Mangal, Director, Global Emergency Response, MUrgency said. PRS ABK

    Kris Gopalakrishnanmedical emergencyMr. Ratan TataMUrgencyShaffi MatherSweta Mangal
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    savita thakur thakur
    savita thakur thakur
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok